COM:TWISTBIOSCIENCE
Twist Bioscience
- Stock
Last Close
41.66
22/11 21:00
Market Cap
2.97B
Beta: -
Volume Today
716.37K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.53M - | 3.93M 157.12% | 6.68M 70.06% | 9.81M 46.87% | 22.04M 124.73% | 35.55M 61.28% | 35.69M 0.37% | 28.07M 21.34% | ||
average payables | 2.59M - | 5.19M 100.15% | 8.65M 66.58% | 7.29M 15.62% | 9.87M 35.23% | 17.50M 77.35% | 17.07M 2.42% | 7.84M 54.07% | ||
average receivables | 1.53M - | 3.88M 153.01% | 8.76M 125.67% | 19.24M 119.60% | 27.46M 42.74% | 34.42M 25.34% | 42.18M 22.54% | 39.48M 6.39% | ||
book value per share | -4.08 - | -8.66 112.40% | -7.57 12.63% | 5.54 173.16% | 8.58 54.94% | 12.04 40.29% | 14.65 21.70% | 10.96 25.19% | 8.15 25.66% | |
capex per share | -0.33 - | -0.43 29.17% | -0.14 67.65% | -0.54 287.72% | -0.25 53.14% | -0.56 122.73% | -1.89 237.04% | -0.49 74.17% | 0.09 117.92% | |
capex to depreciation | -1.47 - | -1.31 10.84% | -0.64 50.97% | -2.41 274.99% | -1.48 38.80% | -2.78 87.80% | -6.17 122.23% | -0.95 84.63% | 0.16 117.04% | |
capex to operating cash flow | 0.16 - | 0.13 20.37% | 0.06 56.63% | 0.17 201.06% | 0.07 58.66% | 0.24 247.55% | 0.82 239.66% | 0.19 76.19% | -0.08 140.62% | |
capex to revenue | -2.75 - | -0.61 77.69% | -0.15 76.32% | -0.27 87.08% | -0.11 59.64% | -0.20 86.71% | -0.50 144.69% | -0.11 77.35% | 0.02 114.31% | |
cash per share | 2.98 - | 4.04 35.73% | 3.03 24.90% | 5.03 65.71% | 7.40 47.14% | 9.90 33.84% | 9.37 5.38% | 5.91 36.89% | 4.76 19.44% | |
days of inventory on hand | 47.58 - | 27.76 41.65% | 68.35 146.21% | 56.41 17.47% | 73.05 29.48% | 143.97 97.10% | 120.23 16.49% | 75.32 37.35% | 48.93 35.04% | |
days payables outstanding | 90.54 - | 43.29 52.19% | 85.40 97.25% | 75.11 12.04% | 28.71 61.78% | 67.46 134.97% | 61.46 8.90% | 33.01 46.29% | 3.31 89.97% | |
days sales outstanding | 116.30 - | 79.53 31.62% | 77.79 2.19% | 81.23 4.43% | 106.85 31.53% | 78.74 26.30% | 72.25 8.25% | 65.62 9.18% | 40.70 37.97% | |
debt to assets | 2.00 - | 2.56 27.72% | 2.74 7.14% | 0.19 93.18% | 0.16 15.91% | 0.17 10.03% | 0.18 3.57% | 0.12 32.28% | 0.14 14.23% | |
debt to equity | -2.00 - | -1.64 17.81% | -1.57 4.11% | 0.23 114.58% | 0.19 18.88% | 0.21 12.12% | 0.22 4.35% | 0.15 30.75% | 0.18 19.21% | |
dividend yield | ||||||||||
earnings yield | -0.17 - | -0.28 64.14% | -0.19 30.53% | -0.16 14.14% | -0.05 71.37% | -0.03 37.30% | -0.11 289.34% | -0.18 54.75% | -0.08 55.15% | |
enterprise value | 245.52M - | 193.42M 21.22% | 301.50M 55.88% | 616.79M 104.57% | 2.92B 373.35% | 4.76B 62.99% | 1.62B 66.06% | 960.09M 40.56% | 2.48B 158.30% | |
enterprise value over ebitda | -6.28 - | -3.64 41.98% | -4.71 29.44% | -5.81 23.33% | -25.11 331.91% | -30.86 22.89% | -6.54 78.81% | -4.97 23.99% | -11.23 125.98% | |
ev to operating cash flow | -6.36 - | -3.77 40.74% | -4.56 20.87% | -7.01 53.92% | -20.52 192.61% | -42.39 106.56% | -12.98 69.37% | -6.74 48.10% | -38.69 474.16% | |
ev to sales | 108.20 - | 17.96 83.40% | 11.86 33.99% | 11.34 4.35% | 32.40 185.72% | 35.96 10.97% | 7.93 77.94% | 3.92 50.63% | 7.92 102.29% | |
free cash flow per share | -2.39 - | -3.76 57.61% | -2.63 30.21% | -3.74 42.46% | -3.88 3.80% | -2.89 25.62% | -4.20 45.43% | -2.99 28.72% | -1.19 60.16% | |
free cash flow yield | -0.17 - | -0.27 57.61% | -0.19 30.21% | -0.16 16.48% | -0.05 67.37% | -0.03 47.18% | -0.12 341.44% | -0.15 23.99% | -0.03 82.14% | |
graham net net | -5.11 - | -10.01 95.91% | -8.62 13.92% | 4.22 148.98% | 6.46 53.10% | 8.16 26.30% | 7.10 12.97% | 4.09 42.47% | 2.98 27.06% | |
graham number | 14.68 - | 27.41 86.72% | 21.35 22.09% | 22.10 3.51% | 26.25 18.79% | 29.22 11.29% | 36.51 24.94% | 29.78 18.42% | 25.68 13.77% | |
income quality | 0.88 - | 0.86 1.19% | 0.93 7.38% | 0.82 12.07% | 1.02 24.47% | 0.74 27.41% | 0.57 22.63% | 0.70 21.96% | 0.31 55.90% | |
intangibles to total assets | 0.03 - | 0.02 19.11% | 0.02 33.50% | 0.01 44.91% | 0.00 58.85% | 0.06 1,500.04% | 0.15 161.19% | 0.18 19.35% | 0.16 9.65% | |
interest coverage | -58.52 - | -64.62 10.43% | -53.74 16.84% | -84.12 56.53% | -149.40 77.61% | -417.60 179.52% | -3.11K 645.39% | -43.43K 1,295.28% | 7.61K 117.53% | |
interest debt per share | 0.64 - | 0.65 2.91% | 0.41 36.57% | 0.33 20.71% | 0.94 185.43% | 1.31 39.80% | 1.76 34.40% | 1.65 6.19% | 1.47 11.41% | |
inventory turnover | 7.67 - | 13.15 71.37% | 5.34 59.38% | 6.47 21.17% | 5.00 22.77% | 2.54 49.26% | 3.04 19.75% | 4.85 59.63% | 7.46 53.94% | |
invested capital | -0.15 - | -0.07 52.97% | -0.05 29.71% | 0.05 205.39% | 0.11 110.44% | 0.11 1.24% | 0.12 10.99% | 0.15 25.49% | 537.41M 356,161,269,027.98% | |
market cap | 262.93M - | 215.49M 18.04% | 372.54M 72.88% | 655.79M 76.03% | 2.98B 353.99% | 5.16B 73.36% | 1.90B 63.21% | 1.15B 39.31% | 2.62B 127.43% | |
net current asset value | -94.03M - | -151.15M 60.73% | -221.54M 46.57% | 125.22M 156.52% | 272.25M 117.41% | 425.22M 56.19% | 424.49M 0.17% | 271.29M 36.09% | 205.14M 24.38% | |
net debt to ebitda | 0.45 - | 0.42 6.65% | 1.11 167.24% | 0.37 66.90% | 0.50 34.95% | 2.61 426.64% | 1.15 56.04% | 1.00 13.31% | 0.64 35.75% | |
net income per share | -2.35 - | -3.85 64.14% | -2.68 30.53% | -3.92 46.45% | -3.57 8.93% | -3.15 11.72% | -4.04 28.26% | -3.60 11.03% | -3.60 0.02% | |
operating cash flow per share | -2.05 - | -3.33 62.20% | -2.49 25.40% | -3.20 28.78% | -3.63 13.36% | -2.33 35.91% | -2.31 0.77% | -2.50 8.50% | -1.10 55.89% | |
payables turnover | 4.03 - | 8.43 109.14% | 4.27 49.30% | 4.86 13.69% | 12.71 161.64% | 5.41 57.44% | 5.94 9.77% | 11.06 86.18% | 110.20 896.60% | |
receivables turnover | 3.14 - | 4.59 46.24% | 4.69 2.24% | 4.49 4.24% | 3.42 23.97% | 4.64 35.69% | 5.05 8.99% | 5.56 10.11% | 8.97 61.20% | |
research and ddevelopement to revenue | 8.03 - | 1.78 77.84% | 0.80 55.05% | 0.66 18.01% | 0.48 27.25% | 0.52 9.35% | 0.59 13.23% | 0.44 26.21% | 0.29 33.44% | |
return on tangible assets | -0.59 - | -0.71 19.39% | -0.63 11.88% | -0.58 7.09% | -0.35 39.39% | -0.23 34.68% | -0.27 16.12% | -0.32 20.46% | -0.41 26.23% | |
revenue per share | 0.12 - | 0.70 479.00% | 0.96 36.60% | 1.98 107.25% | 2.30 16.09% | 2.74 19.29% | 3.78 37.74% | 4.31 14.06% | 5.39 25.20% | |
roe | 0.58 - | 0.44 22.72% | 0.35 20.48% | -0.71 300.18% | -0.42 41.22% | -0.26 37.07% | -0.28 5.39% | -0.33 18.92% | -0.44 34.54% | |
roic | -2.58 - | -2.89 11.98% | 1.33 146.05% | -1.30 198.01% | -0.57 56.23% | 0.62 208.54% | -1.29 308.74% | -0.27 79.18% | -0.39 46.75% | |
sales general and administrative to revenue | ||||||||||
shareholders equity per share | -4.08 - | -8.66 112.40% | -7.57 12.63% | 5.54 173.16% | 8.58 54.94% | 12.04 40.29% | 14.65 21.70% | 10.96 25.19% | 8.15 25.66% | |
stock based compensation to revenue | 0.38 - | 0.18 53.50% | 0.12 33.69% | 0.21 76.37% | 0.19 7.62% | 0.28 47.35% | 0.39 39.97% | 0.12 68.43% | 0.16 31.72% | |
tangible asset value | -78.88M - | -135.42M 71.67% | -203.27M 50.11% | 150.44M 174.01% | 334.82M 122.56% | 540.13M 61.32% | 643.84M 19.20% | 483.14M 24.96% | 372.40M 22.92% | |
tangible book value per share | -4.20 - | -8.80 109.46% | -7.64 13.17% | 5.48 171.71% | 8.54 55.96% | 11.19 31.03% | 11.95 6.74% | 8.49 28.92% | 6.42 24.42% | |
working capital | 50.36M - | 58.39M 15.95% | 77.13M 32.10% | 129.78M 68.25% | 298.84M 130.27% | 483.44M 61.77% | 505.82M 4.63% | 350.93M 30.62% | 275.77M 21.42% |
All numbers in (except ratios and percentages)